Drawing for Serial No. 79137943

USPTO serial 79137943

Serial No. 79137943

Reviewed by CopyMark Law Group

Reg. 4513199Status 404
Filing date
Status date
Registration date
Apr 15, 2014
Examiner
SWAIN, MICHELE LYNN
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with Serial No. 79137943?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
009Computer software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of data and information; computer software for capturing and providing information concerning quality of medication and/or pharmaceuticals and reactions and events resulting from the use of medication and/or pharmaceuticals, enabling follow-up questions and answers regarding said quality, reactions and events and producing reports regarding such quality, reactions and events; computer programs for capturing and providing information concerning quality of medication and/or pharmaceuticals and reactions and events resulting from the use of medication and pharmaceuticals, for enabling follow-up questions and answers regarding said quality, reactions and events and for producing reports regarding such quality, reactions and events, computer software applications for capturing information concerning quality of medication and/or pharmaceuticals, reactions and events resulting from the use of medication and pharmaceuticals, for enabling follow-up questions and answers regarding said reactions and events and for producing reports regarding such quality, reactions and events; computer software for the evaluation and analysis of data and information concerning the quality of medication and/or pharmaceuticals and the reactions and events resulting from the use of medication and/or pharmaceuticalsSECTION 71 - CANCELLED—
038Telecommunications services, namely, transmission of data by means of telecommunications networks, wireless communication networks and the Internet; telecommunication services for providing multiple user access to a global network; transfer of data by telecommunications; transmission and reception of database information via telecommunications networks; data transmission and reception services via telecommunications means; providing telecommunications connections to databases; electronic exchange of data stored in databases accessible via telecommunication networks; communication services, namely, providing electronic transmission of information stored in a database via interactively communicating computer systems; providing multiple use access to global computer information networks for the transfer and dissemination of a wide range of information; information transmission via electronic communications networks; providing multiple user access to proprietary collections of information by means of global computer information networks; telecommunications services, namely, electronic exchange of medical records between patients or health care professionals and pharmaceutical companies; telecommunication services, namely, providing access to an electronic exchange of medical records between patients or health care professionals and pharmaceutical companiesSECTION 71 - CANCELLED—
042Software as a service (SAAS) services featuring software for capturing and providing data concerning quality of medication and/or pharmaceuticals, reactions and events resulting from the use of medication and/or pharmaceuticals, for enabling follow up questions and answers regarding said reactions and events and for producing reports regarding such quality, reactions and events; software as a service (SAAS) services featuring software for evaluating and analyzing data and information concerning the quality of medication and/or pharmaceuticals and the reactions and events resulting from the use of medication or pharmaceuticals; providing temporary use of on-line non-downloadable software which enables the capture of information concerning quality of medication and/or pharmaceuticals, reactions and events resulting from the use of medication and/or pharmaceuticals, which enables follow-up questions and answers regarding said quality, reactions and events and which enables the production of reports regarding said reactions and events; services for maintenance of computer software; providing temporary use of non-downloadable software allowing web site users to send and receive information concerning quality of medication and/or pharmaceuticals used, reactions and events resulting form the use of medication and/or pharmaceuticals, answer and read answers to follow-up questions regarding said quality, reactions and events and produce reports regarding said reactions and events; software as a service (SAAS) services featuring software for collecting, evaluating and analyzing data; design of computer software for reporting reactions and events resulting from the use of medication and/or pharmaceuticals; design of computer software for commercial analysis and reportingSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 17, 2024DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Feb 17, 2024DETHDEATH OF INTERNATIONAL REGISTRATION—
Apr 17, 2022INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Mar 11, 2022INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Mar 10, 2022INPCINVALIDATION PROCESSED—
Oct 26, 2021INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 26, 2021C71TCANCELLED SECTION 71—
Apr 15, 2019REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Aug 1, 2014FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 16, 2014FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 16, 2014FIMPFINAL DISPOSITION PROCESSED—
Jul 15, 2014FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 15, 2014R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 28, 2014NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 28, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 25, 2014GPNXNOTIFICATION PROCESSED BY IB—
Jan 8, 2014OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 8, 2014OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jan 8, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 26, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 26, 2013ALIEASSIGNED TO LIE—
Dec 3, 2013RFNTREFUSAL PROCESSED BY IB—
Dec 3, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 18, 2013TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 18, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 18, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 18, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 13, 2013RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 12, 2013RFRRREFUSAL PROCESSED BY MPU—
Nov 12, 2013MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 9, 2013RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 8, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 7, 2013DOCKASSIGNED TO EXAMINER—
Nov 7, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 4, 2013LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Nov 1, 2013REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance